Obesity, narcolepsy, leukemia and muscle injuries have at least one thing in common: they are engaging the next generation of top stem cell scientists. Five of these scientists presented their research at …
David Hinton’s research is focused on developing novel therapies for age-related macular degeneration (AMD) – the leading cause of irreversible blindness in the elderly. He is approaching this goal in two main …
An innovative therapy using a patient’s own stem cells, modified to resist infection with the AIDS virus, has been given approval by the Food and Drug Administration (FDA) to begin a clinical …
At a special seminar on February 24, USC Stem Cell Principal Investigators discussed their “million-dollar ideas” for creating new tools and technologies to usher in the era of regenerative medicine. They shared …
Los Angeles city and county policymakers and educational institutions laid the groundwork for the region’s biotechnology strategy at a summit on the USC Health Sciences Campus. The Los Angeles Biotech Summit drew …
USC Stem Cell principal investigator Janet Moradian-Oldak has earned a 2015 IADR Innovation in Oral Care Award. The prestigious award, which can be worth up to $75,000 and lasts one year, was …
Three scientists from Keck Medicine of USC have won grants exceeding $4.3 million from the California Institute for Regenerative Medicine (CIRM) for research that includes creating a temporary liver for patients, finding …
Keck Medical Center of USC is offering a new option for patients who need bone marrow (also called stem cell) transplants, but have not found a match. Haploidentical transplants allow patients who …
Resistance of leukemia cells to contemporary chemotherapy is one of the most formidable obstacles to treating acute lymphoblastic leukemia (ALL), the most common form of childhood cancer. Now researchers at Children’s Hospital …
It takes more than materials and methods to be a successful young scientist — it also takes means. With this in mind, the Hearst Foundations have given a gift of $250,000 to …